A report by the European Federation of the Pharmaceutical Industry (Efpia) insists that our continent has lost 25% of its weight in this area in the […]
Increased international competitiveness and digitalisation will require more investment in infrastructure and resources to ensure that our country remains at the forefront of biomedical R&D Source: […]
Farmaindustria explains to Esclerosis Múltiple Euskadi what these studies consist of, how to take part in them and how research into this pathology is progressing Source: […]
Aerospace and defence investment is eight times higher than in the aerospace and defence industry, seven times higher than in the chemical industry, and twice as […]
Oncology, infectious diseases, neurology, haematology and endocrinology are the areas with the highest number of clinical trials with new treatments underway. Seven out of ten molecules […]
Farmaindustria explains to some twenty experts some of the policies and initiatives that have made Spain an international benchmark in clinical drug trials Source: farmaindustria.es Representatives […]
Farmaindustria organises workshops with representatives of the Spanish Data Protection Agency and the Spanish Medicines Agency to continue working on the implementation of the new Code […]
In the framework of its General Assembly, held in Madrid Source: www.actasanitaria.com In the framework of its General Assembly, held in Madrid, Farmaindustria has highlighted, this […]
Representatives of patients’ associations, researchers and experts in health economics debate in the newspaper El Español on the link between health, the economy and the well-being […]
The creation of the European Health Data Space is emerging as a great opportunity to boost R&D for new medicines. Public-private collaboration, once again, at the […]
For the first time in the history of medicine a drug completely kills all patients’ tumours Source: www.larazon.es It’s called dostarlimab, it’s an experimental cancer drug, […]
Farmaindustria’s self-regulation document is the focus of a scientific meeting organised by the Royal National Academy of Pharmacy. Source: www.farmaindustria.es Less than a month ago […]
Source: www.immedicohospitalario.es The Hospital Universitario Puerta de Hierro Majadahonda, led by the Head of the Medical Oncology Department, Dr. Mariano Provencio, is participating in an international […]
Source: www.immedicohospitalario.es Spanish researchers have just published a study that unravels the high intratumoural heterogeneity present in the different subtypes of endometrial cancer (serous and endometrioid) […]
Source: www.immedicohospitalario.es It is among the top 10 cancer research centres in the world and among the top two in Europe. Since its creation in 1998, […]
Since yesterday, the new Clinical Trials Information System (CTIS) has been operational, which centralizes processes with the aim of speeding up these studies Our country starts […]
The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: www.actasanitaria.com With the entry […]
A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]
More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]
Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]
Source: www.immedicohospitalario.es The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]
Source: www.actasanitaria.com Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]
Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]
Via: www.consalud.es The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]
Via: www.immedicohospitalario.es Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]
Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can […]
The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends […]
Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with […]
Pharmacological treatments, together with heart-healthy lifestyles, are the factors that contribute the most to improving the control of these pathologies The pharmaceutical industry has 600 investigational […]
The head of Innovation and director of Innovation at Farmaindustria, Miguel González, highlighted how Artificial Intelligence (AI) has brought about a paradigm shift and a revolution […]
A report by PwC for the European Federation of the Pharmaceutical Industry shows that the pharmaceutical industry contributes an economic value to the EU of 311,000 […]
Farmaindustria presents ‘The pharmaceutical industry and its context in Spain 2024’, the first report that brings together in a single volume all the figures of the […]
One year after the presentation of the ‘Guide of good practice recommendations for the promotion of clinical research in primary care’, promoted by Farmaindustria, successful initiatives […]
Arantxa Sancho, director of the Department of Medical-Scientific Affairs at Farmaindustria, participates in the informative seminar on pharmacogenomic biomarkers organised by the Aemps. Farmaindustria.es On 29 […]
The Farma-Biotech programme facilitates the efficient exchange of information and personal knowledge between research groups, small spin-off companies and the pharmaceutical industry. Since its inception in […]
Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the […]
Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over […]
The Extraordinary General Assembly on Thursday unanimously elected the CEO of Amgen Iberia to lead the Association for the next two years. Source: Farmaindustria.es Fina Lladós […]
There are currently more than 600 clinical trials underway for children and adolescents in Spain, almost half of them focused on rare diseases. The Spanish Network […]
The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]
The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]